Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8

2

Review clinical trials related to Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer

This phase III trial compares the effect of sentinel lymph node mapping to standard lymph node dissection in reducing the risk of swelling in the legs (lymphedema) in patients undergoing a hysterectomy for stage I endometrial cancer. Standard lymph node dissection removes lymph nodes around the uterus during a hysterectomy to look for spread of cancer from the uterus to nearby lymph nodes. Sentinel lymph node mapping uses a special dye and camera to look for cancer that may have spread to nearby lymph nodes. Comparing the results of the procedures may help doctors predict the risk of long-term swelling in the legs.

Participants needed: 428
Trial details
Phase: Phase 3Age: 18+Biological sex: FemaleType: InterventionalSponsor: NRG OncologyUpdated: Aug 7, 2026Locations: 60
Eligibility criteria

Histologically proven diagnosis of endometrial cancer based on endometrial sampl... [+6]

Patients whom the surgeon believes is not a candidate for pelvic lymphadenectomy... [+7]

Status: Not yet recruiting

Web-based Lifestyle Program, mHealth and EMA Intervention, to Improve Weight Loss in Rural Stage I-III Postmenopausal Breast and Endometrial Cancer Survivors, HERO-C Trial

This clinical trial identifies the needs and preferences of rural stage I-III postmenopausal breast and endometrial cancer survivors and evaluates the impact of an adaptive, online program, mobile (m)Health + ecological momentary assessment (EMA) intervention, on lifestyle modification and their weight loss efforts. Obesity, a condition marked by an abnormally high, unhealthy amount of body fat, is associated with lower physical and psychological well-being, higher risk of recurrence, and higher cancer-specific and all-cause mortality (number of deaths). Lifestyle factors, such as low physical activity and unhealthy diet, are the main contributors to obesity that are modifiable. Lifestyle weight loss programs focusing on modifiable factors can improve cancer-specific survival and many aspects of health, but access to these programs can be challenging in rural settings. A remote lifestyle program, adapted to individual goals and needs, may help promote healthy behaviors, improve cancer outcomes, and reduce disease burden in stage I-III postmenopausal breast and endometrial cancer survivors.

Participants needed: 90
Trial details
Age: 40-69Biological sex: FemaleType: InterventionalSponsor: Ohio State University Comprehensive Cancer CenterUpdated: Jul 23, 2026Locations: 1
Eligibility criteria

Body mass index (BMI) ≥ 25kg/m² [+11]

Severe medical conditions, such as unstable cardiovascular disease or digestive... [+3]